08:42 AM EDT, 04/16/2024 (MT Newswires) -- Monopar Therapeutics ( MNPR ) said Tuesday it has filed a provisional patent application with the US Patent and Trademark Office for certain advancements in its MNPR-101 radiopharmaceutical program.

The provisional patent would protect Monopar's proprietary antibody, a MNPR-101-Zr construct, which could be used for treating advanced cancers, the company said.